Medicine and Dentistry
Gut Microbiota
100%
Systematic Review
70%
Gestational Diabetes
52%
Diseases
36%
Diffuse Large B-Cell Lymphoma
35%
Urinary System
35%
Major Depressive Episode
35%
Spontaneous Abortion
35%
Premature Labor
35%
Placebo
35%
Biological Marker
35%
Symptom
33%
Papillomavirus Infection
28%
Disease Course
25%
RNA 16S
24%
Prevalence
22%
Human Milk
22%
Wart Virus
21%
Cohort Analysis
19%
Gene Sequence
18%
Prevotella
18%
Attention Deficit Disorder
17%
B Cell
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Irritable Bowel Syndrome
17%
Diabetes Mellitus
17%
Colorectal Carcinoma
17%
Neonates
17%
Diabetes
17%
Gut Microbiome
17%
Cancer Cell Line
17%
Multiple Myeloma
17%
Drug Effect
17%
Patient with Ulcerative Colitis
17%
Postmenopause
17%
Overactive Bladder
17%
Isoflavone Derivative
17%
Neoplasm
17%
Buffer
17%
Bacterial Growth
17%
Diverticulum
17%
Pervasive Developmental Disorder
17%
Precursor
17%
Fusobacterium nucleatum
17%
Bacteroides fragilis
17%
Alternative RNA Splicing
17%
Feces
17%
Microbiome
17%
Progeny
17%
Adenoma
13%
Keyphrases
Rectal Shedding
17%
Lesion Tissue
17%
Interferon-stimulated Gene 15 (ISG15)
17%
HPV16 E7
17%
IFITM
17%
Fusobacterium nucleatum
17%
Cell Tumor
17%
Cell Precursors
17%
Human B Cells
17%
Attention Deficit Hyperactivity Disorder
17%
Microbial Composition
17%
Autism Spectrum Disorder
17%
Interpersonal Variation
17%
Hofbauer Cells
17%
FODMAP
17%
Breast Milk Microbiota
17%
Phase 2 Randomized Controlled Trial
17%
Vulvar Squamous Cell Carcinoma
14%
Diverticulum
13%
Streptococcus Gallolyticus
13%
Clean Catch
10%
Colorectal Tissue
8%
Prevotella
8%
Porphyromonas
7%
HPV Prevalence
6%
Flinders Resistant Line Rats
6%
Diagnostic Biomarker
5%
Molecular Resistance Mechanism
5%
Drug Therapy
5%
Gene Lists
5%
Screening Analysis
5%
Topoisomerase Inhibitors
5%
Statistical Considerations
5%
Global Gene Expression
5%
Mitotic Inhibitors
5%
B-lineage
5%
Anti-CD20 Antibody
5%
Alkylating Agents
5%
DNA Intercalation
5%
Cancer Hallmarks
5%
Chemotherapy Outcomes
5%
Cancer Cell Phenotype
5%
Drug Screening
5%
Primary Refractory Disease
5%
Bacterial Metabolites
5%
Intestinal Barrier Function
5%
Endocrinal
5%
Diabetic Osteopathy
5%
Lipopolysaccharide-binding Protein
5%
Dialister
5%
Immunology and Microbiology
Intestine Flora
54%
Microflora
49%
B Cell
35%
Feces microflora
21%
Fusobacterium nucleatum
17%
CXCR4
17%
Human Papillomavirus Type 16
17%
Wart Virus
17%
Alternative RNA Splicing
17%
Rituximab
17%
Vaginal Flora
17%
Prevalence
17%
Bacterial Growth
17%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
17%
Schistosomiasis
17%
Praziquantel
17%
Streptococcus gallolyticus
13%
Arm
13%
RNA Gene
12%
Population Research
12%
Gene Sequence
10%
Lipopolysaccharide Binding Protein
8%
Amplicon Sequencing
8%
Room Temperature
8%
Feces
8%
Immunology
8%
Placenta
7%
Embase
7%
Medline
7%
Porphyromonas
6%
Pelvis
6%
Urinary Tract
5%
Normal Human
5%
